Opportunity Overview
The Administration for Strategic Preparedness and Response has an active procurement for Strategic National Stockpile Pharmaceutical Logistic Replenishment, Solicitation 75A50326R00007. The requirement is for a variety of FDA-approved pharmaceuticals supporting Strategic National Stockpile replenishment.
Deadline and Amendment
Amendment 2 extends the proposal deadline to September 21, 2026 at 2:00 PM Eastern Time. The prior September 18 deadline is superseded. Offerors should use the latest SAM.gov notice, Amendment 2, the base RFP, and all posted attachments as the controlling submission package.
Competition and Scope
The current federal notice does not identify a set-aside. The procurement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. Offerors must satisfy the solicitation’s pharmaceutical, quality, regulatory, manufacturing, distribution, logistics, pricing, technical, past-performance, and submission requirements.
Funding / Contract Value
The public notice does not state a fixed maximum contract value.
Qualification Guidance
This opportunity is intended for vendors that can provide the FDA-approved pharmaceutical products and associated replenishment capabilities required by the solicitation. Prospective offerors should verify product eligibility, FDA and other applicable regulatory requirements, delivery and logistics obligations, pricing, technical and past-performance templates, and every amendment in the live federal package before responding.